April 11, 2025 - 11:31

In a bold move aimed at increasing transparency in the real estate market, Zillow has announced that it will no longer permit privately marketed homes, commonly referred to as "pocket" listings, to be featured on its platform. This decision is part of a broader initiative to combat the growing trend of off-market listings that limit access for potential buyers and create an uneven playing field in the housing market.
Pocket listings have been a topic of contention within the industry, as they often benefit a select group of agents and clients while excluding the general public from valuable opportunities. By restricting these listings, Zillow aims to promote fairness and accessibility, ensuring that all homes are marketed openly and widely.
This policy change is expected to spark further discussions among real estate professionals, as the industry grapples with the implications of increased transparency. Zillow's decision highlights a significant shift in the market landscape, prioritizing consumer access and engagement in home buying.
May 14, 2026 - 00:55
Aeluma Announces Third Quarter Fiscal 2026 Financial ResultsAeluma, Inc., a company specializing in compound semiconductor technologies, has released its financial results for the third quarter of fiscal year 2026. The report comes alongside several major...
May 13, 2026 - 11:31
MCK Q1 Deep Dive: Revenue Misses Analyst Expectations as Margin Initiatives ContinueHealthcare distributor McKesson reported first-quarter earnings that missed revenue expectations, though the company continued to push ahead with margin-focused initiatives. For the quarter ending...
May 12, 2026 - 23:07
Prudential Financial Declares Quarterly Dividend on Common StockNEWARK, N.J., May 12, 2026 -- Prudential Financial, Inc. has declared a quarterly dividend of $1.40 per share on its common stock. The payment is scheduled for June 11, 2026, and will go to...
May 12, 2026 - 03:06
Cellectis Reports First Quarter 2026 Financial ResultsCellectis has announced its financial results for the first quarter of 2026, alongside updates on its clinical pipeline and preclinical research programs. The company is advancing its pivotal...